MM-121 (seribantumab)

seribantumab · Merrimack Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MM-121 (seribantumab), covering 2016-03-14 to 2016-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer [Phase 2]